MetaTech AP Unveils 2027 Growth Strategy, Partners with Zheng Yang Biomedical to Build a Regenerative Medicine Supply Chain

ConferencePositive

AI Analysis

Summary

MetaTech AP Inc. held an investor conference presenting 2026 operating performance with NT$1.391 billion revenue (21% YoY growth) and announced a strategic partnership with Zheng Yang Biomedical to build a regenerative medicine supply chain for 2027.

Financial Highlights

Revenue

NT$1.391 billion (first nine months of 2026)

Importance:3/10

Sentiment:

0.30

investor conferenceregenerative medicinesupply chainpartnershipfinancial results

Related Companies

$SHWZ $TRAX

Read the original article

Published by PR Newswire Biotech on October 15, 2026 9:57 AM

Read Original